Pregled bibliografske jedinice broj: 540597
CTLA-4 +49 A/G gene polymorphism in Croatian and Slovenian multiple sclerosis patients
CTLA-4 +49 A/G gene polymorphism in Croatian and Slovenian multiple sclerosis patients // The Seventh ISABS Conference in Forensic, Anthropologic and Medical Genetics and Mayo Clinic Lectures in Translational Medicine ; Final Program and Abstracts / Schanfield, Moses ; Primorac, Dragan ; Vuk-Pavlović, Stanimir (ur.).
Zagreb: International Society for Applied Biological Sciences (ISABS), 2011. str. 273-273 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 540597 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
CTLA-4 +49 A/G gene polymorphism in Croatian and Slovenian multiple sclerosis patients
Autori
Starčević Čizmarević, Nada ; Gašparović, Iva ; Peterlin, Borut ; Sepčić, Juraj ; Rudolf, Gorazd ; Kapović, Miljenko ; Lavtar, Polona ; Ristić, Smiljana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
The Seventh ISABS Conference in Forensic, Anthropologic and Medical Genetics and Mayo Clinic Lectures in Translational Medicine ; Final Program and Abstracts
/ Schanfield, Moses ; Primorac, Dragan ; Vuk-Pavlović, Stanimir - Zagreb : International Society for Applied Biological Sciences (ISABS), 2011, 273-273
Skup
Peti hrvatski kongres iz humane genetke
Mjesto i datum
Bol, otok Brač, Hrvatska, 20.06.2011. - 21.06.2011
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Multiple sclerosis; cytotoxic T lymphocyte antigen 4; gene; polymorphism; association studies
Sažetak
Polymorphisms in the CTLA-4 gene are known to be important in several autoimmune diseases, including multiple sclerosis (MS). Previous studies on the impact of CTLA-4 +49 A/G gene polymorphism have given contradictory results. We investigated the possible influence of this polymorphism on MS susceptibility and disease behavior in Croatian and Slovenian populations. Genotyping was performed in 367 MS patients and 480 control subjects using PCR-RFLP method. The G allele was present in 216 (58.9%) MS patients vs. 282 (58.7%) healthy controls (p = 0.975, OR = 1.01, 95% CI = 0.76-1.32). No significant differences were observed in CTLA-4 +49 A or G allele distribution between patients and controls, indicating that this polymorphism does not influence susceptibility to MS in the surveyed populations. No correlation was observed between G allele carrier status and age at disease onset, disease course, or severity.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
062-1962766-0470 - Genetička analiza multiple skleroze (Ristić, Smiljana, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka
Profili:
Nada Starčević Čizmarević (autor)
Iva Gašparović-Curtini (autor)
Juraj Sepčić (autor)
Smiljana Ristić (autor)
Miljenko Kapović (autor)